Authors: Opolski, A.; Wietrzyk, J.; Siwinska, A.; Marcinkowska, E.; Chrobak, A.; Kutner, A.; Radzikowski, C.

Source: Current Pharmaceutical Design, Volume 6, Number 7, May 2000 , pp. 755-765(11)

Publisher: Bentham Science Publishers

Abstract:

The results of our studies on the biological activity of side-chain modified analogues of vitamin D are reviewed. These analogues appeared to be effective in induction of cell differentiation, inhibition of tumour cell proliferation in vitro and in increasing of antitumour effect of cytostatics. On the other hand, inhibition of cytostatic-induced apoptosis by these compounds was observed. The mechanism of the antiproliferative effect of calcitriol analogues in vitro is discussed. The induction of antigens CD14 and CD11b expression and phagocytic activity of HL-60 cells after exposure to these compounds is related to their effect on cell differentiation. The differentiation of the HL-60 leukaemia cells induced by side-chain modified analogues of calcitriol increases their sensitivity to the antiproliferative effect of cisplatin, doxorubicin and genistein, despite of that this pretreatment causes resistance of these cells to cytostatics-induced apoptosis. We observed a synergistic antiproliferative effect of the combined therapy using analogues of calcitriol with subsequent treatment with the above-mentioned cytostatics. This effect was measured as a significant decrease of the ID 50 values for each cytostatic applied after pretreatment of the tumour cells with the calcitriol analogues.

The results presented suggest that the improved therapeutic effect may be achieved also in vivo by the combined application of the analogues (without calcemic activity) of calcitriol with antitumour agents.

Keywords: Biological Activity; Calcitriol; antigens CD14; CD11b; calcemic activity; antitumor angets; HL 60 Leukaemia Cells; Antiproliferative Activity; Anticance Drugs

Document Type: Research article

Affiliations: 1: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolf Weigl St. 12; 53-114 Wroclaw , Poland,

Publication date: 2000-05-01

More about this publication?

• Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
  
  Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Opolski, A. ;  Wietrzyk, J. ;  Siwinska, A. ;  Marcinkowska, E. ;  Chrobak, A. ;  Kutner, A. ;  Radzikowski, C.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers